ASX:PME Pro Medicus (PME) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Pro Medicus Stock (ASX:PME) 30 days 90 days 365 days Advanced Chart Get Pro Medicus alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume285,954 shsAverage VolumeN/AMarket CapitalizationA$29.16 billionP/E Ratio351.99Dividend Yield0.14%Price TargetN/AConsensus RatingN/A Company Overview Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia. Read More Receive PME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pro Medicus and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PME Stock News HeadlinesThese 3 Aussie stocks could skyrocket and stay there for decadesSeptember 12, 2025 | msn.comPro Medicus Secures ATO for CloudPACS with U.S. Veterans’ AffairsAugust 31, 2025 | tipranks.com$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold stocks — in past bull markets, these plays delivered gains as high as 5,000% to 9,800%, and Sean has now identified five companies he believes could see explosive moves in the early stages of what may be the biggest gold rally yet.September 16 at 2:00 AM | Weiss Ratings (Ad)Dr Boreham’s Crucible: Homegrown imaging hero Pro Medicus eyes a big slice of the American pieAugust 25, 2025 | msn.comPro Medicus Limited Expands ASX Quotation with New SecuritiesAugust 25, 2025 | msn.comPro Medicus Limited Announces Cessation of SecuritiesAugust 25, 2025 | tipranks.comDoes Macquarie rate Pro Medicus shares a buy after they surged again on FY25 results?August 18, 2025 | msn.comInvestors overly optimistic on ASX highflyerAugust 17, 2025 | morningstar.com.auMSee More Headlines PME Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Pro Medicus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pro Medicus investors own include Mineral Resources (MIN), ResMed (RMD), Technology One (TNE), ARB (ARB), Accent Group (AX1), Cochlear (COH) and CSL (CSL). Company Calendar Ex-Dividend for 9/24 Dividend9/02/2025Today9/16/2025Record date for 9/24 Dividend9/24/2025Dividend Payable9/24/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:PME CIKN/A Webwww.promed.com.au Phone61 3 9429 8800FaxN/AEmployees2,060Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$0.78 Trailing P/E Ratio351.99 Forward P/E RatioN/A P/E Growth3.87Net IncomeA$82.79 million Net Margins51.27% Pretax MarginN/A Return on Equity47.73% Return on Assets30.68% Debt Debt-to-Equity Ratio1.10 Current Ratio5.98 Quick Ratio4.39 Sales & Book Value Annual SalesA$161.50 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow71.76 Book ValueA$1.80 per share Price / BookN/AMiscellaneous Outstanding Shares104,500,000Free FloatN/AMarket CapA$29.16 billion OptionableNot Optionable Beta0.56 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (ASX:PME) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro Medicus Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro Medicus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PME Stock Alerts